Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 687,800 | 673,300 | 684,100 | 587,000 | 714,800 |
| Cost of Goods | 306,500 | 293,600 | 289,900 | 287,800 | 343,900 |
| Gross Profit | 381,300 | 379,700 | 394,200 | 299,200 | 370,900 |
| Operating Expenses | 778,000 | 376,100 | 359,600 | 339,000 | 420,300 |
| Operating Income | -396,200 | 4,200 | 35,500 | -39,000 | -48,500 |
| Interest Expense | 12,200 | 15,000 | 10,000 | 3,300 | 15,600 |
| Other Income | 5,100 | 2,900 | 1,200 | 200 | 1,200 |
| Pre-tax Income | -403,300 | -7,900 | 26,700 | -42,100 | -62,900 |
| Income Tax | -17,000 | 2,000 | 5,200 | -11,200 | -33,900 |
| Net Income Continuous | -386,300 | -9,900 | 21,500 | -30,900 | -29,000 |
| Net Income Discontinuous | -5,800 | -51,900 | 29,000 | 37,200 | N/A |
| Net Income | $-392,100 | $-61,800 | $50,500 | $6,300 | $-29,000 |
| EPS Basic Total Ops | -8.53 | -1.32 | 1.08 | 0.13 | -0.61 |
| EPS Basic Continuous Ops | -8.40 | -0.21 | 0.46 | -0.64 | -0.61 |
| EPS Basic Discontinuous Ops | -0.13 | -1.11 | 0.62 | 0.77 | N/A |
| EPS Diluted Total Ops | -8.53 | -1.32 | 1.07 | 0.13 | -0.61 |
| EPS Diluted Continuous Ops | -8.40 | -0.21 | 0.46 | -0.64 | -0.61 |
| EPS Diluted Discontinuous Ops | -0.13 | -1.11 | 0.61 | 0.77 | N/A |
| EPS Diluted Before Non-Recurring Items | 1.35 | 1.03 | 1.65 | 1.15 | 0.79 |
| EBITDA(a) | $86,000 | $50,300 | $83,200 | $-700 | $-5,600 |